In our study, the expression of MRP1 in GBM cells did not match the drug sensitivity profiles and thus we cannot safely conclude whether this, or other resistance proteins, significantly contributed to the final drug response in the present model. The gene discussed is ABCC1; the disease is glioblastoma.